nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—Diethylpropion—SLC6A3—malignant glioma	0.0337	0.497	CrCbGaD
Milnacipran—Extrapyramidal disorder—Temozolomide—malignant glioma	0.0247	0.0265	CcSEcCtD
Milnacipran—Endocrine disorder—Temozolomide—malignant glioma	0.0225	0.0241	CcSEcCtD
Milnacipran—Pethidine—CYP2B6—malignant glioma	0.0184	0.271	CrCbGaD
Milnacipran—Dry eye—Temozolomide—malignant glioma	0.0172	0.0185	CcSEcCtD
Milnacipran—Pethidine—SLC6A3—malignant glioma	0.0157	0.231	CrCbGaD
Milnacipran—Hot flush—Temozolomide—malignant glioma	0.0145	0.0155	CcSEcCtD
Milnacipran—Menopausal symptoms—Temozolomide—malignant glioma	0.0143	0.0154	CcSEcCtD
Milnacipran—Thirst—Temozolomide—malignant glioma	0.0142	0.0152	CcSEcCtD
Milnacipran—Hyponatraemia—Carmustine—malignant glioma	0.0141	0.0151	CcSEcCtD
Milnacipran—Liver function test abnormal—Carmustine—malignant glioma	0.0129	0.0139	CcSEcCtD
Milnacipran—Dry skin—Temozolomide—malignant glioma	0.0124	0.0133	CcSEcCtD
Milnacipran—Breast disorder—Temozolomide—malignant glioma	0.0122	0.0131	CcSEcCtD
Milnacipran—Abdominal distension—Temozolomide—malignant glioma	0.0118	0.0126	CcSEcCtD
Milnacipran—Neutropenia—Carmustine—malignant glioma	0.0113	0.0121	CcSEcCtD
Milnacipran—Dysuria—Temozolomide—malignant glioma	0.0109	0.0117	CcSEcCtD
Milnacipran—Neutropenia—Temozolomide—malignant glioma	0.0109	0.0117	CcSEcCtD
Milnacipran—Upper respiratory tract infection—Temozolomide—malignant glioma	0.0109	0.0117	CcSEcCtD
Milnacipran—Pollakiuria—Temozolomide—malignant glioma	0.0108	0.0116	CcSEcCtD
Milnacipran—Erectile dysfunction—Temozolomide—malignant glioma	0.0108	0.0116	CcSEcCtD
Milnacipran—Weight decreased—Temozolomide—malignant glioma	0.0106	0.0113	CcSEcCtD
Milnacipran—Urinary tract infection—Carmustine—malignant glioma	0.0105	0.0112	CcSEcCtD
Milnacipran—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.0103	0.0111	CcSEcCtD
Milnacipran—Urinary tract infection—Temozolomide—malignant glioma	0.0101	0.0109	CcSEcCtD
Milnacipran—Hepatobiliary disease—Temozolomide—malignant glioma	0.00986	0.0106	CcSEcCtD
Milnacipran—Hallucination—Carmustine—malignant glioma	0.00964	0.0103	CcSEcCtD
Milnacipran—Hypoaesthesia—Carmustine—malignant glioma	0.00964	0.0103	CcSEcCtD
Milnacipran—Oedema peripheral—Carmustine—malignant glioma	0.00954	0.0102	CcSEcCtD
Milnacipran—Connective tissue disorder—Carmustine—malignant glioma	0.00952	0.0102	CcSEcCtD
Milnacipran—Hepatitis—Temozolomide—malignant glioma	0.00936	0.01	CcSEcCtD
Milnacipran—Hypoaesthesia—Temozolomide—malignant glioma	0.00931	0.00999	CcSEcCtD
Milnacipran—Hallucination—Temozolomide—malignant glioma	0.00931	0.00999	CcSEcCtD
Milnacipran—Urinary tract disorder—Temozolomide—malignant glioma	0.00924	0.00991	CcSEcCtD
Milnacipran—Oedema peripheral—Temozolomide—malignant glioma	0.00922	0.00989	CcSEcCtD
Milnacipran—Connective tissue disorder—Temozolomide—malignant glioma	0.0092	0.00986	CcSEcCtD
Milnacipran—Urethral disorder—Temozolomide—malignant glioma	0.00917	0.00984	CcSEcCtD
Milnacipran—Eye disorder—Carmustine—malignant glioma	0.00905	0.00971	CcSEcCtD
Milnacipran—Flushing—Carmustine—malignant glioma	0.00899	0.00964	CcSEcCtD
Milnacipran—Erythema multiforme—Temozolomide—malignant glioma	0.00885	0.00949	CcSEcCtD
Milnacipran—Eye disorder—Temozolomide—malignant glioma	0.00875	0.00938	CcSEcCtD
Milnacipran—Flushing—Temozolomide—malignant glioma	0.00869	0.00932	CcSEcCtD
Milnacipran—Cardiac disorder—Temozolomide—malignant glioma	0.00869	0.00932	CcSEcCtD
Milnacipran—Angiopathy—Temozolomide—malignant glioma	0.00849	0.00911	CcSEcCtD
Milnacipran—Mental disorder—Carmustine—malignant glioma	0.00848	0.0091	CcSEcCtD
Milnacipran—Mediastinal disorder—Temozolomide—malignant glioma	0.00843	0.00905	CcSEcCtD
Milnacipran—Malnutrition—Carmustine—malignant glioma	0.00843	0.00904	CcSEcCtD
Milnacipran—Chills—Temozolomide—malignant glioma	0.0084	0.00901	CcSEcCtD
Milnacipran—Mental disorder—Temozolomide—malignant glioma	0.0082	0.00879	CcSEcCtD
Milnacipran—Malnutrition—Temozolomide—malignant glioma	0.00815	0.00874	CcSEcCtD
Milnacipran—Dysgeusia—Temozolomide—malignant glioma	0.00798	0.00856	CcSEcCtD
Milnacipran—Vision blurred—Carmustine—malignant glioma	0.00794	0.00852	CcSEcCtD
Milnacipran—Tremor—Carmustine—malignant glioma	0.0079	0.00847	CcSEcCtD
Milnacipran—Agitation—Carmustine—malignant glioma	0.00775	0.00831	CcSEcCtD
Milnacipran—Vision blurred—Temozolomide—malignant glioma	0.00768	0.00824	CcSEcCtD
Milnacipran—Tremor—Temozolomide—malignant glioma	0.00763	0.00819	CcSEcCtD
Milnacipran—Leukopenia—Carmustine—malignant glioma	0.00755	0.00809	CcSEcCtD
Milnacipran—Agitation—Temozolomide—malignant glioma	0.00749	0.00803	CcSEcCtD
Milnacipran—Convulsion—Carmustine—malignant glioma	0.0073	0.00783	CcSEcCtD
Milnacipran—Leukopenia—Temozolomide—malignant glioma	0.00729	0.00782	CcSEcCtD
Milnacipran—Hypertension—Carmustine—malignant glioma	0.00728	0.00781	CcSEcCtD
Milnacipran—Palpitations—Temozolomide—malignant glioma	0.0072	0.00772	CcSEcCtD
Milnacipran—Chest pain—Carmustine—malignant glioma	0.00718	0.0077	CcSEcCtD
Milnacipran—Anxiety—Carmustine—malignant glioma	0.00715	0.00767	CcSEcCtD
Milnacipran—Convulsion—Temozolomide—malignant glioma	0.00706	0.00757	CcSEcCtD
Milnacipran—Hypertension—Temozolomide—malignant glioma	0.00703	0.00754	CcSEcCtD
Milnacipran—Anxiety—Temozolomide—malignant glioma	0.00691	0.00741	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00689	0.00739	CcSEcCtD
Milnacipran—Infection—Carmustine—malignant glioma	0.00684	0.00733	CcSEcCtD
Milnacipran—Dry mouth—Temozolomide—malignant glioma	0.00678	0.00728	CcSEcCtD
Milnacipran—Thrombocytopenia—Carmustine—malignant glioma	0.00674	0.00723	CcSEcCtD
Milnacipran—Tachycardia—Carmustine—malignant glioma	0.00671	0.0072	CcSEcCtD
Milnacipran—Infection—Temozolomide—malignant glioma	0.00661	0.00709	CcSEcCtD
Milnacipran—Anorexia—Carmustine—malignant glioma	0.00656	0.00703	CcSEcCtD
Milnacipran—Nervous system disorder—Temozolomide—malignant glioma	0.00652	0.00699	CcSEcCtD
Milnacipran—Thrombocytopenia—Temozolomide—malignant glioma	0.00651	0.00698	CcSEcCtD
Milnacipran—Skin disorder—Temozolomide—malignant glioma	0.00646	0.00693	CcSEcCtD
Milnacipran—Hypotension—Carmustine—malignant glioma	0.00643	0.0069	CcSEcCtD
Milnacipran—Hyperhidrosis—Temozolomide—malignant glioma	0.00643	0.00689	CcSEcCtD
Milnacipran—Anorexia—Temozolomide—malignant glioma	0.00634	0.0068	CcSEcCtD
Milnacipran—Insomnia—Carmustine—malignant glioma	0.00622	0.00667	CcSEcCtD
Milnacipran—Paraesthesia—Carmustine—malignant glioma	0.00618	0.00663	CcSEcCtD
Milnacipran—Dyspnoea—Carmustine—malignant glioma	0.00613	0.00658	CcSEcCtD
Milnacipran—Somnolence—Carmustine—malignant glioma	0.00612	0.00656	CcSEcCtD
Milnacipran—Insomnia—Temozolomide—malignant glioma	0.00601	0.00645	CcSEcCtD
Milnacipran—Decreased appetite—Carmustine—malignant glioma	0.00598	0.00642	CcSEcCtD
Milnacipran—Paraesthesia—Temozolomide—malignant glioma	0.00597	0.0064	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Carmustine—malignant glioma	0.00594	0.00637	CcSEcCtD
Milnacipran—Dyspnoea—Temozolomide—malignant glioma	0.00593	0.00636	CcSEcCtD
Milnacipran—Somnolence—Temozolomide—malignant glioma	0.00591	0.00634	CcSEcCtD
Milnacipran—Constipation—Carmustine—malignant glioma	0.00588	0.00631	CcSEcCtD
Milnacipran—Dyspepsia—Temozolomide—malignant glioma	0.00585	0.00628	CcSEcCtD
Milnacipran—Decreased appetite—Temozolomide—malignant glioma	0.00578	0.0062	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00574	0.00616	CcSEcCtD
Milnacipran—Fatigue—Temozolomide—malignant glioma	0.00573	0.00615	CcSEcCtD
Milnacipran—Constipation—Temozolomide—malignant glioma	0.00569	0.0061	CcSEcCtD
Milnacipran—Gastrointestinal pain—Carmustine—malignant glioma	0.00563	0.00603	CcSEcCtD
Milnacipran—Body temperature increased—Carmustine—malignant glioma	0.00544	0.00583	CcSEcCtD
Milnacipran—Abdominal pain—Carmustine—malignant glioma	0.00544	0.00583	CcSEcCtD
Milnacipran—Gastrointestinal pain—Temozolomide—malignant glioma	0.00544	0.00583	CcSEcCtD
Milnacipran—Urticaria—Temozolomide—malignant glioma	0.00528	0.00567	CcSEcCtD
Milnacipran—Body temperature increased—Temozolomide—malignant glioma	0.00526	0.00564	CcSEcCtD
Milnacipran—Abdominal pain—Temozolomide—malignant glioma	0.00526	0.00564	CcSEcCtD
Milnacipran—Hypersensitivity—Carmustine—malignant glioma	0.00507	0.00544	CcSEcCtD
Milnacipran—Asthenia—Carmustine—malignant glioma	0.00494	0.00529	CcSEcCtD
Milnacipran—Hypersensitivity—Temozolomide—malignant glioma	0.0049	0.00525	CcSEcCtD
Milnacipran—Asthenia—Temozolomide—malignant glioma	0.00477	0.00512	CcSEcCtD
Milnacipran—Diarrhoea—Carmustine—malignant glioma	0.00471	0.00505	CcSEcCtD
Milnacipran—Pruritus—Temozolomide—malignant glioma	0.0047	0.00505	CcSEcCtD
Milnacipran—Dizziness—Carmustine—malignant glioma	0.00455	0.00488	CcSEcCtD
Milnacipran—Diarrhoea—Temozolomide—malignant glioma	0.00455	0.00488	CcSEcCtD
Milnacipran—Dizziness—Temozolomide—malignant glioma	0.0044	0.00472	CcSEcCtD
Milnacipran—Vomiting—Carmustine—malignant glioma	0.00437	0.00469	CcSEcCtD
Milnacipran—Rash—Carmustine—malignant glioma	0.00434	0.00465	CcSEcCtD
Milnacipran—Dermatitis—Carmustine—malignant glioma	0.00433	0.00465	CcSEcCtD
Milnacipran—Headache—Carmustine—malignant glioma	0.00431	0.00462	CcSEcCtD
Milnacipran—Vomiting—Temozolomide—malignant glioma	0.00423	0.00453	CcSEcCtD
Milnacipran—Rash—Temozolomide—malignant glioma	0.00419	0.0045	CcSEcCtD
Milnacipran—Dermatitis—Temozolomide—malignant glioma	0.00419	0.00449	CcSEcCtD
Milnacipran—Headache—Temozolomide—malignant glioma	0.00417	0.00447	CcSEcCtD
Milnacipran—Nausea—Carmustine—malignant glioma	0.00409	0.00438	CcSEcCtD
Milnacipran—Nausea—Temozolomide—malignant glioma	0.00395	0.00424	CcSEcCtD
